Article
Innate Immune Receptor NLRX1: Potential Modulator of Glioblastoma Pathophysiology
2024-09-20
Abstract excerpt
Gliomas are primary brain tumors that develop from glial cells within the central nervous system and are among the deadliest human cancers. Glioblastoma (GBM) is the most malignant form of glioma. NLRX1 is an innate immune pattern recognition receptor that exhibits tumor-suppressive and tumor-promoting effects that may be cancer or cell-type, context-dependent, aided by differences in the microenvironment. Here, w...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dbd43f09-3725-5c6e-9b28-2aebe8a68470
- DOI
- 10.1101/2024.09.19.613932
